Perineural invasion in cancer

Cancer - Tập 115 Số 15 - Trang 3379-3391 - 2009
Catherine Liebig1, Gustavo Ayala2, Jonathan A. Wilks1, David H. Berger1, R. Daniel Beauchamp1
1Department of Surgery, Michael E. DeBakey Veterans Affairs Medical Center, Baylor College of Medicine, Houston, Texas
2Department of Pathology, Baylor College of Medicine, Houston, Texas

Tóm tắt

Abstract

Perineural invasion (PNI) is the process of neoplastic invasion of nerves and is an under‐recognized route of metastatic spread. It is emerging as an important pathologic feature of many malignancies, including those of the pancreas, colon and rectum, prostate, head and neck, biliary tract, and stomach. For many of these malignancies, PNI is a marker of poor outcome and a harbinger of decreased survival. PNI is a distinct pathologic entity that can be observed in the absence of lymphatic or vascular invasion. It can be a source of distant tumor spread well beyond the extent of any local invasion; and, for some tumors, PNI may be the sole route of metastatic spread. Despite increasing recognition of this metastatic process, there has been little progress in the understanding of molecular mechanisms behind PNI and, to date, no targeted treatment modalities aimed at this pathologic entity. The objectives of this review were to lay out a clear definition of PNI to highlight its significance in those malignancies in which it has been studied best. The authors also summarized current theories on the molecular mediators and pathogenesis of PNI and introduced current research models that are leading to advancements in the understanding of this metastatic process. Cancer 2009. © 2009 American Cancer Society.

Từ khóa


Tài liệu tham khảo

Cruveilheir J, 1835, Maladies Des Nerfs Anatomie Pathologique Du Corps Humain

10.1007/BF01929317

10.1007/BF02482964

10.1097/01.sla.0000133185.23514.32

10.1016/S0360-3016(03)01433-0

10.1097/00000658-199604000-00007

10.1007/s005950300020

10.1177/000348948509400420

10.1097/00000478-198004000-00006

10.1002/1097-0142(196710)20:10<1772::AID-CNCR2820201028>3.0.CO;2-#

10.1007/BF00222433

Peters A, 1991, The Fine Structure of the Nervous System: Neurons and Their Supporting Cells, 494

Stolinski C, 1995, Structure and composition of the outer connective tissue sheaths of peripheral nerve, J Anat., 186, 123

Olsson Y, 1990, Microenvironment of the peripheral nervous system under normal and pathological conditions, Crit Rev Neurobiol., 5, 265

10.1016/0002-9610(66)90309-6

10.1046/j.1440-0960.2000.00408.x

10.1001/archotol.124.6.637

10.1016/0016-5085(94)90080-9

Nagakawa T, 1991, Patterns of neural and plexus invasion of human pancreatic cancer and experimental cancer, Int J Pancreatol., 10, 113, 10.1007/BF02924114

Reina MA, 2000, Morphology of peripheral nerves, their sheaths, and their vascularization [in Spanish], Rev Esp Anestesiol Reanim., 47, 464

10.1002/pros.1137

10.1016/S0090-4295(02)02426-3

10.1016/j.ydbio.2005.12.048

10.1038/sj.cdd.4401707

10.1385/MN:27:3:277

10.1016/S0303-7207(97)00165-2

Ketterer K, 2003, Reverse transcription‐PCR analysis of laser‐captured cells points to potential paracrine and autocrine actions of neurotrophins in pancreatic cancer, Clin Cancer Res., 9, 5127

10.1023/B:CLIN.0000046131.24625.54

10.1002/(SICI)1097-0215(19990331)81:1<67::AID-IJC13>3.0.CO;2-V

10.1067/msy.2003.239

10.1200/JCO.1999.17.8.2419

Zhang Y, 2005, Expression of nerve growth factor receptors and their prognostic value in human pancreatic cancer, Oncol Rep., 14, 161

10.1002/mc.10083

10.1007/BF01269888

10.1053/hupa.2002.128249

10.1002/(SICI)1097-0215(19990505)81:3<417::AID-IJC16>3.0.CO;2-6

10.1007/BF02905254

Djakiew D, 1993, Chemotaxis and chemokinesis of human prostate tumor cell lines in response to human prostate stromal cell secretory proteins containing a nerve growth factor‐like protein, Cancer Res., 53, 1416

10.1006/exnr.1997.6498

10.1016/0016-5085(91)90226-B

10.1097/01.mpa.0000175176.40045.0f

10.1016/S0001-6519(05)78579-4

Bosland MC, 1990, Characterization of adenocarcinomas of the dorsolateral prostate induced in Wistar rats by N‐methyl‐N‐nitrosourea, 7,12‐dimethylbenz(a)anthracene, and 3,2′‐dimethyl‐4‐aminobiphenyl, following sequential treatment with cyproterone acetate and testosterone propionate, Cancer Res., 50, 700

10.1136/jcp.36.3.269

10.1288/00005537-198610000-00015

10.5858/2005-129-354-PAVIIO

10.1016/0002-9610(84)90385-4

10.1002/hed.2890080603

10.1053/clon.2000.9198

10.1097/01.pas.0000149687.90710.21

10.1002/hed.10334

10.1002/hed.10025

10.1097/01.coc.0000251224.16075.60

Pilch BZ, 2005, Upper Aerodigestic Tract Cancer Protocols and Checklists

10.1053/hupa.2001.26456

10.1158/0008-5472.CAN-04-0838

10.1016/S0022-5347(17)38881-X

10.1097/00000478-199304000-00003

10.1016/S0090-4295(99)00350-7

10.1097/00005392-200101000-00029

10.1097/01.pas.0000160980.62586.05

10.1002/cncr.22388

10.1016/j.ijrobp.2007.01.039

10.1159/000049791

10.1046/j.1464-410x.2000.00518.x

10.1038/modpathol.2008.81

10.1097/01.ju.0000143973.22897.f8

Miyake H, 2005, Limited value of perineural invasion in radical prostatectomy specimens as a predictor of biochemical recurrence in Japanese men with clinically localized prostate cancer, Hinyokika Kiyo., 51, 241

10.1159/000070139

10.1046/j.1464-410X.1997.33011.x

10.1002/(SICI)1096-9098(199707)65:3<164::AID-JSO4>3.0.CO;2-4

10.1097/00006676-200305000-00002

10.1097/00006676-200201000-00003

Noto M, 2005, Pancreas head carcinoma: frequency of invasion to soft tissue adherent to the superior mesenteric artery, Am J Surg Pathol., 29, 1056, 10.1097/01.pas.0000167055.13614.b9

10.1002/(SICI)1097-0142(19961215)78:12<2485::AID-CNCR6>3.0.CO;2-J

10.1097/00006676-199605000-00006

10.1002/1097-0142(19920215)69:4<930::AID-CNCR2820690416>3.0.CO;2-R

10.1007/BF02051074

10.1016/S0344-0338(11)80333-X

Matsushima T, 1998, Preoperative estimation of neural invasion in rectal carcinoma, Oncol Rep., 5, 73

Moore PA, 1984, Adenocarcinoma of the colon and rectum in patients less than 40 years of age, Am Surg., 50, 10

10.1038/bjc.1992.19

10.1016/S0002-9610(99)00080-X

10.1002/1097-0142(19880301)61:5<1018::AID-CNCR2820610527>3.0.CO;2-H

10.1016/S0002-9610(05)80517-3

10.1093/jjco/hyh054

10.1007/BF02234390

10.1007/BF02052215

10.1159/000077348

10.1016/j.ctrv.2008.10.001

10.3748/wjg.v8.i5.943

10.1002/bjs.1800800526

10.1245/ASO.2003.05.001

10.1002/(SICI)1097-0142(19981215)83:12<2509::AID-CNCR15>3.0.CO;2-V

10.1002/(SICI)1096-9896(199705)182:1<29::AID-PATH820>3.0.CO;2-#

10.1007/s10434-000-0416-z

10.1007/BF02725334

10.1002/1097-0142(19861101)58:9<1995::AID-CNCR2820580907>3.0.CO;2-1

10.1093/ajcp/78.6.817

College of American Pathologists, 2007, Cancer Protocols and Checklists

10.1016/j.jss.2004.06.003

10.1517/13543784.16.3.303

Desmet CJ, The neurotrophic receptor TrkB: a drug target in anticancer therapy?, Cell Mol Life Sci., 2996, 755

10.1158/0008-5472.CAN-07-1183

Miknyoczki SJ, 2002, The neurotrophin‐trk receptor axes are critical for the growth and progression of human prostatic carcinoma and pancreatic ductal adenocarcinoma xenografts in nude mice, Clin Cancer Res., 8, 1924